Farrukh Awan, MD, is a professor in the Department of Internal Medicine and the director of Lymphoid Malignancies at the Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center. He specializes in stem cell transplant, cellular therapies (including chimeric antigen receptor [CAR] T-cell therapy), and evaluation of novel therapies for the treatment of patients with lymphoid malignancies.
Dr. Awan is a member of several professional organizations, including the American Medical Association, the American Society of Clinical Oncology, and the American Society of Hematology. He is also the recipient of the Young Investigator Award from the American Society of Clinical Oncology and the Clinical Career Development Award from the Lymphoma Research Foundation. He has delivered scores of presentations, administered multiple grants and clinical trials, and published numerous academic articles and book chapters.
Dr. Awan is certified by the American Board of Internal Medicine, the American Board of Medical Oncology, and the American Board of Hematology. He completed a fellowship in hematology and oncology at The Ohio State University and his residency in internal medicine at the University of Pittsburgh Medical Center.